ABI starts a strategic collaboration with Agenus

We are glad to announce a strategic collaboration with Agenus, a US-based biotech company specializing in innovative forms of cancer treatment, including the discovery and development of immuno-oncology therapies. Together with the scientists at Agenus, ABI will form a team of students and researchers to study cancer metastases and identify potential biomarkers and targets for cancer immunotherapies.This collaboration is also part of our long-term vision of supporting biotech developments in Armenia.